Literature DB >> 18779787

Actemra poised to launch IL-6 inhibitors.

Lisa Melton, Amy Coombs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779787     DOI: 10.1038/nbt0908-957

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

Review 1.  Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.

Authors:  Simon A Jones; Jürgen Scheller; Stefan Rose-John
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

2.  Plasmacytoid dendritic cell-derived IFN-α promotes murine liver ischemia/reperfusion injury by induction of hepatocyte IRF-1.

Authors:  Antonino Castellaneta; Osamu Yoshida; Shoko Kimura; Shinichiro Yokota; David A Geller; Noriko Murase; Angus W Thomson
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 3.  Tocilizumab.

Authors:  Adith Venkiteshwaran
Journal:  MAbs       Date:  2009-09-10       Impact factor: 5.857

Review 4.  Current stage in inflammatory bowel disease: What is next?

Authors:  Gonzalo Jesús Gómez-Gómez; Ángeles Masedo; Carmen Yela; Maria del Pilar Martínez-Montiel; Begoña Casís
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

5.  Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.

Authors:  Christoph Garbers; Wolfgang Thaiss; Gareth W Jones; Georg H Waetzig; Inken Lorenzen; Florence Guilhot; Rami Lissilaa; Walter G Ferlin; Joachim Grötzinger; Simon A Jones; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

6.  Genetic evidence for an essential role of neuronally expressed IL-6 signal transducer gp130 in the induction and maintenance of experimentally induced mechanical hypersensitivity in vivo and in vitro.

Authors:  Serena Quarta; Christian Vogl; Cristina E Constantin; Nurcan Üçeyler; Claudia Sommer; Michaela Kress
Journal:  Mol Pain       Date:  2011-09-27       Impact factor: 3.395

7.  Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.

Authors:  Ken Tawara; Julia T Oxford; Cheryl L Jorcyk
Journal:  Cancer Manag Res       Date:  2011-05-18       Impact factor: 3.989

8.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Authors:  Daniel I Swerdlow; Michael V Holmes; Karoline B Kuchenbaecker; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Yiran Guo; Christina Chung; Anne Peasey; Roman Pfister; Simon P Mooijaart; Helen A Ireland; Maarten Leusink; Claudia Langenberg; Ka Wah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; John Hardy; Michael A Nalls; Yun Rose Li; Gordon Lowe; Marlene Stewart; Suzette J Bielinski; Julian Peto; Nicholas J Timpson; John Gallacher; Malcolm Dunlop; Richard Houlston; Ian Tomlinson; Ioanna Tzoulaki; Jian'an Luan; Jolanda M A Boer; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Luigi Ferrucci; Stefania Bandenelli; Toshiko Tanaka; James F Meschia; Andrew Singleton; Gerjan Navis; Irene Mateo Leach; Stephan J L Bakker; Ron T Gansevoort; Ian Ford; Stephen E Epstein; Mary Susan Burnett; Joe M Devaney; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Yolanda van der Graaf; Pim A de Jong; Anke-Hilse Mailand-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Jeffrey W Stephens; Charles B Eaton; Jennifer G Robinson; JoAnn E Manson; F Gerry Fowkes; Timonthy M Frayling; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Susan Redline; Leslie A Lange; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Emelia J Benjamin; John C Whittaker; Anders Hamsten; Frank Dudbridge; J A Chris Delaney; Andrew Wong; Diana Kuh; Rebecca Hardy; Berta Almoguera Castillo; John J Connolly; Pim van der Harst; Eric J Brunner; Michael G Marmot; Christina L Wassel; Steve E Humphries; Philippa J Talmud; Mika Kivimaki; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Hakon Hakonarson; Alex P Reiner; Brendan J Keating; Naveed Sattar; Aroon D Hingorani; Juan Pablo Casas
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

Review 9.  Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.

Authors:  Harald Loppnow; Michael Buerke; Karl Werdan; Stefan Rose-John
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

10.  Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis.

Authors:  Tomohito Sato; Shinya Minakuchi; Manabu Mochizuki; Masaru Takeuchi
Journal:  Clin Ophthalmol       Date:  2014-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.